Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at three upcoming investor conferences. The first presentation will be at the Robert W. Baird 2011 Health Care Conference in New York, NY.   
Event: Robert W. Baird 2011 Health Care Conference
Date: Thursday, September 8, 2011
Time: 11:30 a.m. ET

The second presentation will be at the 2011 Morgan Stanley Global Healthcare Unplugged Conference in New York, NY.

Event: 2011 Morgan Stanley Global Healthcare Unplugged Conference
Date: Tuesday, September 13, 2011
Time: 2:45 p.m. ET

The third presentation will be at the UBS 2011 Global Life Sciences Conference in New York, NY.

Event: UBS 2011 Global Life Sciences Conference
Date: Tuesday, September 20, 2011
Time: 8:00 a.m. ET

An audio webcast of the Company's presentations will be available by visiting the investor relations section of Endologix's website at www.endologix.com.  A replay of the presentations will be available for 30 days.

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. The Nellix® Endovascular System and Ventana™ Fenestrated Stent Graft System are investigational devices. Additional information can be found on Endologix's Web site at www.endologix.com.

CONTACT: COMPANY CONTACT:
         Endologix, Inc.
         John McDermott, CEO
         (949) 595-7200
         www.endologix.com
         
         INVESTOR CONTACTS:
         The Ruth Group
         Nick Laudico (646) 536-7030
         Zack Kubow (646) 536-7020
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Endologix Charts.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Endologix Charts.